Decades of medical advice told patients to finish every last antibiotic pill in their prescription. A new survey of 1,475 American adults shows this message remains firmly planted in the public mind, even as scientific consensus shifts. Clinical trials now indicate that shorter courses are often just as effective as longer ones for treating common bacterial respiratory infections. Despite this data, nearly 9 in 10 Americans still believe they must finish a full bottle to stay safe.
The findings, published in Open Forum Infectious Diseases, highlight a disconnect between updated clinical guidance and patient expectations. Researchers found that about 60 percent of respondents prefer a prescription lasting seven days or more. Many participants equated longer treatment duration with higher effectiveness and a lower risk of infection recurrence. This view is largely rooted in decades of consistent messaging from doctors and public health campaigns.
Surprisingly, there is room for change. While only a small fraction of patients reported receiving advice to stop medication once symptoms subside, more than half indicated they would feel comfortable following that exact guidance if provided by their own physician. Most people maintain high levels of trust in their doctors, suggesting that personalized communication is the most effective way to update these outdated perceptions.
Instead of relying on blanket slogans, experts recommend that healthcare providers explain the reasoning behind shorter treatment courses on a case-by-case basis. Patients are more likely to accept shorter durations when their clinician provides context grounded in current medical evidence. The goal is not to abandon safety, but to align treatment lengths with what scientific study now proves to be sufficient for recovery. Shifting these habits will require clear, honest dialogue rather than broad public health mandates.